Similarly, in gliomas, reduced NEDD4L expression was associated with aggressive progression and worse prognoses [19], suggesting that NEDD4L could be a tumor suppressor that inhibits tumorigenesis. This evidence concerns the gene NEDD4L and central nervous system cancer.